Previous Article | Next Article ![]()
J. Virol., Jun 1997, 4226-4232, Vol 71, No. 6
R Anderson, S Wang, C Osiowy and AC Issekutz
Although endothelial cells have been speculated to be a target in the
pathogenesis of dengue hemorrhagic fever (DHF), there has been little
evidence linking dengue virus infection to any alteration in endothelial
cell function. In this study, we show that human umbilical vein endothelial
cells become activated when exposed to culture fluids from dengue
virus-infected peripheral blood monocytes. Maximum activation was achieved
with culture fluids from monocytes in which virus infection was enhanced by
the addition of dengue virus-immune serum, thus correlating with
epidemiological evidence that prior immunity to dengue virus is a major
risk factor for DHF. Activation was strongest for endothelial cell
expression of VCAM-1 and ICAM-1. In contrast, activation of endothelial
cell E-selectin expression appeared to be more transient, as indicated by
its detection at 3 h, but not at 16 h, of treatment. Treatment of monocyte
culture fluids with anti- tumor necrosis factor alpha (TNF-alpha) antibody
largely abolished the activation effect (as measured by endothelial cell
expression of ICAM- 1), whereas treatment with IL-1beta receptor antagonist
had a much smaller inhibitory effect on activation. Endothelial cells
inoculated directly with dengue virus or with virus-antibody combinations
were poorly infectable (compared to Vero cells or peripheral blood
monocytes), and virus-inoculated endothelial cells showed no increased
expression of VCAM-1, ICAM-1, or E-selectin. Taken together, the results
strongly indicate that dengue virus can modulate endothelial cell function
by an indirect route, in which a key intermediary is TNF- alpha released
from virus-infected monocytes.
Copyright © 1997, American Society for Microbiology
Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes
Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada. Anderson@Tupdean1.med.dal.ca
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|